Noticias de ANTX_US

Noticias del mercado

Últimas noticias sobre ANTX_US — 85 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ANTX_US ✕ 85 resultados
10/04/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) director receives 3,775-share fully vested grant
10/04/2026 ANTX_US — The Globe and Mail
AN2 Therapeutics Launches New $80 Million ATM Program
10/04/2026 ANTX_US — Minichart
AN2 Therapeutics, Inc. Announces Open Market Sale Agreement with Jefferies for Common Stock (8-K Filing)
09/04/2026 ANTX_US — TradingView
An2 Therapeutics Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing
09/04/2026 ANTX_US — Stock Titan
AN2 Therapeutics (NASDAQ: ANTX) launches new $80M at-the-market stock sale
09/04/2026 ANTX_US — Stock Titan
AN2 Therapeutics (NASDAQ: ANTX) launches $80M at‑the‑market share program
09/04/2026 ANTX_US — Investing.com
AN2 Therapeutics enters $80 million at-the-market sales agreement with Jefferies
09/04/2026 ANTX_US — MarketScreener
An2 Therapeutics Inc may offer and sell up to $300 million of securities - SEC filing
09/04/2026 ANTX_US — MarketScreener
An2 Therapeutics Inc - enters open market sale agreement with Jefferies for up to $80 million common stock - SEC filing
09/04/2026 ANTX_US — TipRanks
AN2 Therapeutics Launches New $80 Million ATM Program
09/04/2026 ANTX_US — TradingView
An2 Therapeutics Inc - Enters Open Market Sale Agreement With Jefferies For Up To $80 Million Common Stock - SEC Filing
31/03/2026 ANTX_US — Yahoo Finance
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
31/03/2026 ANTX_US — Investing.com
AN2 Therapeutics launches phase 2 trial for lung infection drug
31/03/2026 ANTX_US — BioSpace
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
31/03/2026 ANTX_US — Business Wire
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
24/03/2026 ANTX_US — Stock Titan ES ← EN
Presentaciones ANTX ante la SEC: AN2 Therapeutics, Inc. Formularios 10-K, 10-Q, 8-K
23/03/2026 ANTX_US — Stock Titan
[Form 4] AN2 Therapeutics, Inc. Insider Trading Activity
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) reprices Chief Development Officer stock options
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) reprices stock options for company director
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) director logs repriced stock options and cancels older grants

Página 3 de 5

keyboard_arrow_up